Download full-text PDF

Source

Publication Analysis

Top Keywords

[isoproterenol hemodynamic
4
hemodynamic study
4
study obstructive
4
obstructive heart
4
heart disease]
4
[isoproterenol
1
study
1
obstructive
1
heart
1
disease]
1

Similar Publications

Introduction: Sotalol is a beta-adrenoceptor blocking drug with unique physical and pharmacologic properties. Unlike most beta-adrenoceptor blocking drugs, sotalol is amenable to extracorporeal removal and causes QT interval prolongation and ventricular dysrhythmias. These properties have implications for treating sotalol poisoning.

View Article and Find Full Text PDF

Objective: This study evaluated the safety and efficacy of isoproterenol administration as an adjunct for achievement of target heart rate (HR) during dobutamine stress echocardiography (DSE).

Background: In DSE, optimal accuracy is achieved when a target HR of 85% of maximal predicted heart rate (MPHR) is attained. Although rarely studied, intravenous isoproterenol has been used as an adjunct therapy to dobutamine and atropine to increase chronotropic response during pharmacologic stress testing.

View Article and Find Full Text PDF

Basic pharmacological evaluation of modified phenyl carbamic acid derivatives on cardiovascular functions under in vitro conditions in rats.

Gen Physiol Biophys

January 2025

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Comenius University, Bratislava, Slovakia.

The study aimed to evaluate the basic pharmacological effects of modified phenyl carbamic acid derivates with a basic part made of N-phenylpiperazine (compounds 6a, 6b, 6c, 6d) in Wistar rats. The compounds were evaluated for their ability to decrease the phenylephrine-induced contraction of the aortic strips of rats after repeated administration of the compounds and their ability to inhibit the positive chronotropic effect of isoproterenol on spontaneously beating rat atria. The ability to inhibit the vasoconstriction effect of phenylephrine was confirmed in all compounds in the range from 10.

View Article and Find Full Text PDF

Preprocedural Screening Tool to Guide Nonpulmonary Vein Trigger Testing in First-Time Atrial Fibrillation Ablation.

Circ Arrhythm Electrophysiol

January 2025

Section of Cardiac Electrophysiology, Division of Cardiovascular Medicine, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA.

Background: Patients undergoing first-time atrial fibrillation (AF) ablation can benefit from targeting non-pulmonary vein (PV) triggers. Preprocedural identification of high-risk individuals can guide planning of ablation strategy. This study aimed to create a preprocedural screening tool to identify patients at risk of non-PV triggers during first-time AF ablation.

View Article and Find Full Text PDF

Chronotropic and Inotropic Effects of Sudachitin, a Polymethoxyflavone from the Peel of Citrus sudachi on Isolated Rat Atria and Its Underlying Mechanisms.

Biol Pharm Bull

December 2024

Laboratory of Functional Food Sciences, Department of Health and Bio-Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, Mukogawa Women's University.

Article Synopsis
  • - Sudachitin, a polymethoxyflavone from sudachi peel, shows promise in improving hyperlipidemia but its effects on heart function were investigated, revealing that it enhances heart rate and contractility in rat atria in a dose-dependent manner.
  • - Unlike isoproterenol, which has a stronger impact, sudachitin and other similar compounds like demethoxysudachitin and nobiletin also increase heart function but to a lesser degree; their effects appear non-specific across these compounds.
  • - The study found that sudachitin enhances heart function through cAMP-dependent pathways rather than through β-adrenoceptors, suggesting a unique mechanism for its action among polymethoxyflavones.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!